Tagged parnell

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018
Press Release

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Three Months Ended 30 September 2018

 Parnell delivers 39% revenue growth and a $5.9 million year-to-date improvement in EBITDA as at the third quarter of 2018 compared to the same period in 2017, consolidates the return to profitability, and maintains full-year 2018 guidance at a 35 - 40% increase over 2017 revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million. Read More
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018
Press Release

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended 30 June 2018

 Parnell delivers 32% revenue growth and a $4.0 million improvement in EBITDA in the first six months of 2018 compared to the same period in 2017, returns to profitability for the first time post-IPO and increases 2018 guidance to a 35% - 40% increase in revenue to $26 - $27 million and an EBITDA range of $5.5 - $6.5 million. Read More
Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management
Press Release

Parnell Pharmaceuticals Holdings Completes Debt Refinancing With Marathon Asset Management

 Read More
Notice of General Meeting and Explanatory Memorandum
Press Release

Notice of General Meeting and Explanatory Memorandum

 Read More
Parnell Appoints Tony G Hartnell AM to Board of Directors
Press Release

Parnell Appoints Tony G Hartnell AM to Board of Directors

 Appointment adds an eminent corporate governance expert to the Board as a new Independent Director Read More
Results of General Meeting of Shareholders held December 29, 2017
Press Release

Results of General Meeting of Shareholders held December 29, 2017

 Read More
Notice of Annual General Meeting and Explanatory Memorandum
Press Release

Notice of Annual General Meeting and Explanatory Memorandum

 Read More
Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017
Press Release

Parnell Pharmaceuticals Holdings Ltd Announces Business Results for the Six Months Ended June 30, 2017

 Parnell continues strong revenue growth, increasing 25% to $10.3 million for the six months ended June 30, 2017 Read More